Related Experiment Video
Updated: Mar 29, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Routinely analyzed leukocyte characteristics improve prediction of mortality after coronary angiography
Crystel M Gijsberts1, Guilielmus Hjm Ellenbroek2, Maarten J Ten Berg3
1Experimental Cardiology Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands ICIN-Netherlands Heart Institute, the Netherlands.
Insights
Routine blood tests reveal leukocyte characteristics that significantly improve the prediction of mortality in patients with coronary artery disease (CAD). These findings enhance risk assessment for coronary angiography patients.
Area of Science:
- Cardiology
- Hematology
- Biomarkers
Background:
- Inflammation and leukocyte infiltration are key features of atherosclerosis.
- Standard hematology analyzers provide unutilized leukocyte data.
- This data may correlate with coronary artery disease (CAD) severity and patient outcomes.
Purpose of the Study:
- To investigate if routinely measured leukocyte characteristics predict CAD severity.
- To assess if these characteristics improve mortality prediction in coronary angiography patients.
Main Methods:
- 1015 patients undergoing coronary angiography were studied.
- Leukocyte characteristics were analyzed using automated hematology analyzers.
- Patients were followed for mortality and major adverse cardiovascular events (MACEs).
Main Results:
- Monocyte percentage independently predicted all-cause mortality.
- Monocyte-to-lymphocyte ratio best predicted cardiovascular mortality.
- Leukocyte characteristics improved mortality risk prediction, but not for MACEs.
Conclusions:
- Unreported leukocyte data from routine analyzers enhance mortality prediction in coronary angiography patients.
- This offers a valuable, readily available tool for risk stratification.
- Further research may integrate these markers into clinical practice.
Background:
Inflammation and leukocyte infiltration are hallmarks of atherosclerosis. Clinically routine hematology analyzers mostly perform an entire differential blood count by default, irrespective of the requested parameter. We hypothesize that these normally unreported leukocyte characteristics associate with coronary artery disease (CAD) severity and can improve prediction of mortality in coronary angiography patients.
Methods:
We studied coronary angiography patients suspected of CAD (n = 1015) from the Utrecht Coronary Biobank cohort. Leukocyte characteristics were routinely assessed in blood drawn directly prior to angiography using an automated hematology analyzer and extracted from the Utrecht patient oriented database (UPOD) database. Patients were followed up for a median duration of 805 days, during which 65 patients died. We evaluated the association of leukocyte characteristics with synergy between PCI with taxus and cardiac surgery (SYNTAX) score as a measure of CAD severity, all-cause and cardiovascular mortality and major adverse cardiovascular events (MACEs). In order to determine the improvement of risk prediction, we calculated continuous net reclassification improvement (cNRI) and integrated discrimination improvement (IDI).
Results:
Monocyte percentage showed strong independent predictive value for all-cause mortality (hazard ratio (HR) 1.44 (1.19-1.74), p < 0.001), and the monocyte-to-lymphocyte ratio performed best for cardiovascular mortality (HR 1.42 (1.11-1.81), p = 0.005). The cNRIs and IDIs of leukocyte characteristics for all-cause mortality confirmed the improvement in mortality risk prediction. No significantly predictive leukocyte characteristics were found for MACEs.
Conclusion:
Readily available yet unreported leukocyte characteristics from routine hematology analyzers significantly improved prediction of mortality in coronary angiography patients on top of clinical characteristics.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:58Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...